Mutations Seen Among Patients with Pheochromocytoma and Paraganglioma at a Referral Center From India

作者：Pai R; Ebenazer A; Paul M J; Thomas N; Nair A; Seshadri M S; Oommen R; Shanthly N; Devasia A; Rebekah G; Jeyaseelan L; Rajaratnam S^*

来源：Hormone and Metabolic Research, 2015, 47(2): 133-137.

DOI：10.1055/s-0034-1376989

• pheochromocytoma
• paraganglioma
• India
• SDHx
• genetic screening

Determining the mutational status of susceptibility genes including RET, VHL, SDHx (SDHB, SDHC, SDHD) among patients with pheochromocytoma/paraganglioma (PCC/PGL) is gaining importance. These genes have not been systematically characterized among patients with PCC/PGL from India. The aim of the work was to screen the most frequently mutated genes among patients with PCC/PGL to determine the frequency and spectrum of mutations seen in this region. Fifty patients with PCC/PGL treated at our tertiary care hospital between January 2010 and June 2012 were screened for mutations in susceptibility genes using an algorithmic approach. Thirty-two percent (16/50) of patients were found to be positive for mutations including mutations among RET (n = 4), VHL (n = 6), SDHB (n = 3), and SDHD (n = 3) genes. None of these patients were positive for SDHC mutations. A significant association was found between young patients with bilateral tumors and VHL mutations (p = 0.002). Two of the 3 patients with extra-adrenal SDHB associated tumors, had unique mutations, viz., c.436delT (exon 5) and c.788_857del (exon 8), one of which was malignant. High frequency of mutations seen among patients in this study emphasizes the need to consider mutational analysis among Indian patients with PCC/PGL.

• 出版日期2015-2